Skip to main content
Clinical Trials/NCT05303987
NCT05303987
Recruiting
Phase 2

Trial of Dexmedetomidine Versus Propofol Sedation for Drug-Induced Sleep Endoscopy in Pediatric Obstructive Sleep Apnea

Erin Kirkham2 sites in 1 country90 target enrollmentOctober 5, 2022

Overview

Phase
Phase 2
Intervention
Propofol sedation
Conditions
Obstructive Sleep Apnea
Sponsor
Erin Kirkham
Enrollment
90
Locations
2
Primary Endpoint
Mean obstruction score at the tongue base
Status
Recruiting
Last Updated
3 months ago

Overview

Brief Summary

This research study is designed to learn, first, whether two anesthetics have different effects on collapse seen within the upper airway during sleep endoscopy. A second purpose is to learn whether collapse at several levels of the upper airway is associated with obstructive sleep apnea that persists after adenotonsillectomy, the surgery that removes the tonsils and adenoids.

Registry
clinicaltrials.gov
Start Date
October 5, 2022
End Date
August 31, 2026
Last Updated
3 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Erin Kirkham
Responsible Party
Sponsor Investigator
Principal Investigator

Erin Kirkham

Assistant Professor of Otolaryngology-Head and Neck Surgery

University of Michigan

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with Obstructive sleep apnea (OSA) by the following criteria: Obstructive Apnea Index (OAI) ≥ 1 or Apnea Hypopnea Index (AHI) ≥ 1.5, confirmed on nocturnal, laboratory-based polysomnography within the previous 12 months scored using American Academy of Sleep Medicine pediatric criteria in an accredited sleep lab.
  • Considered to be a surgical candidate for adenotonsillectomy to treat OSA by an board-certified or board-eligible otolaryngologist.
  • Clinical determination by the child's otolaryngologist surgeon that the child would benefit from sleep endoscopy prior to adenotonsillectomy due to one or more reported risk factors for residual sleep apnea after surgery, which may include:
  • Obese (\>95th percentile of body mass index for age)
  • Severe preoperative OSA (AHI ≥10 events/hour)
  • Discordance between awake physical exam (eg. small tonsils) and sleep apnea symptoms or severity;
  • African American race
  • Age ≥7 years old
  • Male or Female ages 3.00 - 11.99 years of age at the time of consent
  • Parent/guardian ability to understand and willingness to sign a written informed consent..

Exclusion Criteria

  • Previous adenotonsillectomy or other upper airway surgery (including tracheostomy) with the exception of isolated adenoidectomy if it occurred \>18 months prior to recruitment.
  • Major medical diagnosis that may be exacerbated by the study treatment, pose undue risk to the patient, or that may impact interpretation of study results
  • History of allergic reaction to or contraindication to receiving propofol, dexmedetomidine, ketamine or sevoflurane
  • Allergy to eggs, egg products, soybeans or soybean products.
  • Contraindication to receiving general anesthesia

Arms & Interventions

Propofol sedation

2.5 mg/kg loading dose, then continue at an infusion of 250 mcg/kg/minute.

Intervention: Propofol sedation

Dexmedetomidine sedation

1 mcg/kg loading dose, then continue at an infusion of 1 mcg/kg/hour

Intervention: Dexmedetomidine sedation

Outcomes

Primary Outcomes

Mean obstruction score at the tongue base

Time Frame: During Drug Induced Sleep Endoscopy (DISE) procedure, as judged subsequently by video review by the three raters

The degree of obstruction is scored on a 4-point scale as 0% (0), \<50% (1), 50-99% (2), or 100% (3). Scores from the 3 surgeons will be averaged for use in analysis.

Study Sites (2)

Loading locations...

Similar Trials